Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

By LabMedica International staff writers
Posted on 15 Feb 2024

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique. Over the past decade, PA imaging has gained traction as a practical imaging modality in various clinical settings where it has demonstrated encouraging results. While traditional diagnostic methods are invasive, PA imaging offers a noninvasive alternative for examining biological tissues. However, its broad clinical application has been hampered by the bulkiness and high cost of laser sources. Now, researchers have introduced a groundbreaking, compact, and affordable PA sensing instrument for biomedical tissue diagnosis. Their proof-of-concept study, utilizing cost-effective diode lasers, marks a significant step toward the transition of PA imaging from laboratory research to clinical application.

For the study, researchers from the IIT Indore (Madhya Pradesh, India) focused on the complex nature of breast tissue, specifically fibrocystic changes, which often present diagnostic challenges due to similarities with breast cancer. These changes can cause breast pain and detectable cysts and are frequently found in peritumoral breast parenchyma, complicating diagnoses. Traditional diagnostic methods like ultrasound and mammography sometimes lack the necessary precision, and fine needle aspiration cytology, a common diagnostic tool, often requires additional invasive procedures for confirmation. The PA technique, leveraging laser diodes, generates acoustic waves that provide critical insights into tissue composition and density.

The novel instrument incorporates multiple laser diodes in a compact design, coupled with a custom-built pulsed current supply unit, producing efficient PA excitation with 25 nanosecond pulses at 20 kHz. The researchers were able to distinguish between normal and diseased breast tissues by analyzing the frequency spectra of PA signals. Analyzing the frequency spectra allowed for quantitative tissue assessment. For example, fibrocystic breast disease showed a dominant frequency peak at around 1.60 MHz, suggesting increased tissue density, while normal breast tissue had a lower peak frequency of 0.26 MHz, indicative of its fibrofatty composition.

Histopathological examinations confirmed these observations, aligning spectral responses with tissue characteristics. The experimental setup differentiated tissue types based on quantitative spectral parameters, enhancing diagnostic accuracy and potentially simplifying the sampling process for pathological breast tissues. The compact PA sensing instrument could emerge as a promising tool for clinical practice, offering rapid, reliable, and cost-effective breast disease diagnosis. This breakthrough paves the way for timely interventions and improved patient outcomes, revolutionizing biomedical practices with a cost-effective and rapid tissue diagnosis approach.

Related Links:
IIT Indore

New
Gold Member
Human Chorionic Gonadotropin Test
hCG Quantitative - R012
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
New
Silver Member
ACTH Assay
ACTH ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.